Cranebio is a biotechnology company that develops healthcare solutions such as self-testing kits for easy and accessible health monitoring.
Cranebio has raised $1.7M in total funding. The most recent round was Series A. The last funding was announced in October 2023.
Cranebio's investors include Nippon Venture Capital, Axil Capital, Akigin Capital Partners.
Cranebio is headquartered in Tokyo, Japan.
Cranebio is a biotechnology company that develops healthcare solutions such as self-testing kits for easy and accessible health monitoring.
Cranebio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cranebio — Funding & Investors." VCBacked, October 4, 2023, https://www.vcbacked.co/company/cranebio. Accessed August 15, 2026.
VCBacked. (2023). Cranebio — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/cranebio
{{cite web |title=Cranebio — Funding & Investors |url=https://www.vcbacked.co/company/cranebio |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated